We are very pleased to announce that Proacta S.A. has obtained financing for the implementation of the project entitled “Development of a platform for automatic analysis of laboratory test results based on the Dbam o Siebie Smart LAB solution.”

The aim of the project is to develop an improved medical device based on the entrepreneur’s existing research results, which have enabled the implementation of the Dbam o Siebie Smart LAB analytical platform, an innovative tool supporting users in the analysis of laboratory test results. The project will involve research and development work, continuing the existing research, which will result in a new Class IIa medical device.

The planned development of the platform includes:

• Expansion of the scope of analyzed tests: Currently, the platform analyzes basic blood tests. The project aims to include a wider range of tests in the analysis, such as urine tests, hormone tests, etc., which will allow for a more comprehensive assessment of health.
• Increasing the number of detectable diseases: The development of the platform’s analytical algorithms will enable the identification of a wider range of potential health problems, including rare diseases that are difficult to diagnose based on standard tests.
• Development of functionality dedicated to physicians: New functionalities will assist physicians in the diagnostic process, allowing them to access patient results, generate extended reports, and monitor treatment progress over time.
• Obtaining additional information from the patient about their clinical condition.
• Preparing a personalized list of recommended laboratory, genetic, and/or imaging tests.
• Implementing an intuitive user interface for the analytical platform, providing the patient with access to personalized health information, with the option of downloading the report as a PDF file.

Target groups Solutions:

• Patients – people interested in actively managing their health, monitoring test results, and receiving personalized recommendations. In particular, the solution is dedicated to patients who need support in the diagnosis of metabolic and cardiovascular diseases.
• Medical facilities – hospitals, clinics, and care facilities can use the platform to expand their services, streamline patient care processes, improve the quality of care, and increase the efficiency of the facility.
• Diagnostic laboratories – adding a personalized interpretation of results service may increase patient interest in performing follow-up tests on their own, which is particularly important from the perspective of private diagnostic centers.
• Employers – making the platform’s functionality available to their employees as part of a well-being program may increase their productivity and reduce sick leave.

Project value: PLN 5,622,480.00

EU co-financing: PLN 3,980,544.00

The implementation of the project will contribute to improving the quality of healthcare, as the platform will enable faster and more accurate diagnostics, which will shorten the waiting time for a visit to a specialist and allow for earlier implementation of treatment. Another effect of the project will be to increase public health awareness—platform users will have access to reliable and understandable information about their health, enabling them to make informed decisions about prevention and treatment.